164 related articles for article (PubMed ID: 34126903)
1. A Natural Membrane Vesicle Exosome-based Sinomenine Delivery Platform for Hepatic Carcinoma Therapy.
Wang Y; Zhao L; Yuan W; Liang L; Li M; Yu X; Wang Y
Curr Top Med Chem; 2021 Oct; 21(14):1224-1234. PubMed ID: 34126903
[TBL] [Abstract][Full Text] [Related]
2. Effects of sinomenine on a rat orthotopic liver carcinoma model.
Zhang Y; Ran H; Hui S; Qian L
Histol Histopathol; 2024 Jun; 39(6):795-804. PubMed ID: 38084512
[TBL] [Abstract][Full Text] [Related]
3. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
[TBL] [Abstract][Full Text] [Related]
4. Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer.
Cao J; Huang J; Gui S; Chu X
Int J Nanomedicine; 2021; 16():3725-3739. PubMed ID: 34103913
[TBL] [Abstract][Full Text] [Related]
5. Sinomenine exerts antitumour effect in gastric cancer cells via enhancement of miR-204 expression.
Yuan H; Zhang J; Li F; Li W; Wang H
Basic Clin Pharmacol Toxicol; 2019 Nov; 125(5):450-459. PubMed ID: 31243880
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
7. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
[TBL] [Abstract][Full Text] [Related]
8. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
Liang L; Zhao L; Wang Y; Wang Y
Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
[TBL] [Abstract][Full Text] [Related]
9. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
10. Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.
Huang MB; Gao Z; Xia M; Zhao X; Fan X; Lin S; Zhang L; Huang L; Wei A; Zhou H; Wu JY; Roth WW; Bond VC; Leng J
Int J Physiol Pathophysiol Pharmacol; 2022; 14(2):90-113. PubMed ID: 35619665
[TBL] [Abstract][Full Text] [Related]
11. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.
Jiang L; Gu Y; Du Y; Tang X; Wu X; Liu J
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42411-42428. PubMed ID: 34464081
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.
Lv LH; Wan YL; Lin Y; Zhang W; Yang M; Li GL; Lin HM; Shang CZ; Chen YJ; Min J
J Biol Chem; 2012 May; 287(19):15874-85. PubMed ID: 22396543
[TBL] [Abstract][Full Text] [Related]
13. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633
[TBL] [Abstract][Full Text] [Related]
14. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties.
Wang S; Xu M; Li X; Su X; Xiao X; Keating A; Zhao RC
J Hematol Oncol; 2018 Jun; 11(1):82. PubMed ID: 29898759
[TBL] [Abstract][Full Text] [Related]
15. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
[TBL] [Abstract][Full Text] [Related]
16. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
17. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro.
Qu Z; Wu J; Wu J; Luo D; Jiang C; Ding Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):159. PubMed ID: 27716356
[TBL] [Abstract][Full Text] [Related]
19. 4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest.
Liu S; Zhao Y; Cui HF; Cao CY; Zhang YB
J BUON; 2016; 21(5):1195-1202. PubMed ID: 27837623
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
